Trial
NCT00724061
Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
National Cancer Institute (NCI)
Condition
Lymphoma
Intervention
Pegylated interferon α-2b
Why stopped
Closed early due to poor accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-12-12